Hubei Jumpcan Pharmaceutical Co (SHSE:600566) Moat Score: 0/10 (As of Jul. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600566 Hubei Jumpcan Pharmaceutical Co Ltd SHSE:600566
81 GF Score
Price ¥27.47
GF Value ¥21.02
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Hubei Jumpcan Pharmaceutical Co Moat Score?

Hubei Jumpcan Pharmaceutical Co has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

Hubei Jumpcan Pharmaceutical Co has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Hubei Jumpcan Pharmaceutical Co might have No Moat - No discernible moat.

Hubei Jumpcan Pharmaceutical Co  (SHSE:600566) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Hubei Jumpcan Pharmaceutical Co Moat Score Related Terms

SHSE:600566
81GF Score
Hubei Jumpcan Pharmaceutical Co Ltd SHSE:600566
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Hubei Jumpcan Pharmaceutical Co (SHSE:600566) Overvalued in 2026?

Based on GuruFocus' analysis, Hubei Jumpcan Pharmaceutical Co stock appears to be overvalued. The current stock price of ¥27.47 is trading 30.7% above its estimated GF Value™ of ¥21.02. GuruFocus considers Hubei Jumpcan Pharmaceutical Co to be Significantly Overvalued.

Key valuation signals for SHSE:600566:

  • Moat Score: 0
  • GF Value™: ¥21.02 vs. price of ¥27.47 (30.7% above fair value)
  • GF Score™: 81/100 with 6 warning signs

No single metric tells the full story. See the SHSE:600566 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hubei Jumpcan Pharmaceutical Co Business Description

Address Daqing West Road, Baota Bay, Jiangsu Province, Taixing, CHN, 225441
Hubei Jumpcan Pharmaceutical Co Ltd engages in the research, development, manufacturing, and trading of Chinese traditional medicines, western medicines, daily use chemicals based on Chinese traditional medicines, and Chinese medicine health products in China. It offers Chinese and Western medicines in the areas of pediatrics, gynecology, pneumonology, gastroenterology, and geriatrics. The company also develops Chinese and Western medicines in the areas of detoxification, digestive system, respiratory system, nervous system, anti-infection, cardiovascular, narcotic analgesic, nutrition, musculoskeletal, and hemostasis.
81GF Score

Get the complete analysis for SHSE:600566

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥27.47
Price
¥21.02
GF Value